Chewy, Inc. current report, 30 October 2023

Chewy, Inc. Form 8-K Summary

Business Context and Reporting Period

Chewy, Inc. filed this Current Report on Form 8-K on October 30, 2023, to report transactions with affiliates of BC Partners LLP. The filing concerns a corporate restructuring completed on October 30, 2023, rather than a quarterly or annual financial report.

Transaction and Governance Changes

  • Chewy completed a merger in which Buddy Chester Sub Parent Holdco, Inc. merged into Chewy Kentucky Holding, LLC, a wholly owned subsidiary of Chewy.
  • Chewy Pharmacy KY, LLC became an indirect wholly owned subsidiary of Chewy.
  • BC Partners’ aggregate ownership, voting power, economic interest, and number of Class B shares did not change as a result of the transaction. No other outstanding capital stock changed.
  • Buddy Holdco paid Chewy cash for certain inherited tax obligations and Chewy transaction expenses. The filing does not provide a dollar amount.
  • The transaction was approved by a special committee of independent and disinterested directors and subsequently approved by the Board.

Amended Investor Rights

  • Chewy and BC Partners-affiliated stockholders entered into an Amended and Restated Investor Rights Agreement.
  • Board nomination rights will decline as BC Partners’ ownership falls below specified thresholds, ending when ownership is below 5%.
  • For specified ownership levels, BC Partners is subject to standstill restrictions and limitations on certain change-of-control proposals without approval from an independent committee.
  • BC Partners agreed to transfer restrictions, including limits on transfers during the first six and twelve months after closing.
  • The dual-class capital structure will be phased out over five years. Required Class B-to-Class A conversions occur on each anniversary of closing, with all remaining Class B shares scheduled for conversion on the fifth anniversary.

Financial Metrics and Liquidity

This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, guidance, or other operating-performance metrics. It also does not disclose the amount of cash paid at closing.

Material Changes, Risks, and Contingencies

  • Chewy succeeded to certain tax and other contingent liabilities of Buddy Holdco and its predecessors.
  • Buddy Chester is required to indemnify Chewy for specified tax liabilities and certain contingent liabilities, including liabilities related to pre-closing periods and specified breaches of representations and warranties.
  • Class B shares were placed in escrow to secure potential indemnification obligations, and additional shares must be retained and kept available for that purpose. The filing does not provide the number of shares.
  • If actual inherited tax liabilities exceed the cash provided at closing, Buddy Chester must pay the shortfall when the relevant tax returns are filed. If liabilities are lower, Chewy must pay the excess cash back to Buddy Chester.
  • The transactions were intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code, but the filing does not provide an independent tax opinion or quantify potential tax exposure.

Most Important Facts to Verify

  • The cash amount delivered for taxes and transaction expenses.
  • The number and value of Class B shares placed in escrow and retained for indemnification.
  • Chewy’s resulting ownership of Chewy Pharmacy KY, LLC and any related accounting impact.
  • The timing and execution of the mandated Class B-to-Class A share conversions.
  • Any tax liabilities, contingent claims, or indemnification payments ultimately arising from the transaction.
  • The detailed terms in Exhibit 2.1, the Merger Agreement, and Exhibit 10.1, the Amended and Restated Investor Rights Agreement.